Palisade Bio (PALI) Receivables - Other (2016 - 2023)
Palisade Bio (PALI) posted quarterly Receivables - Other of $105625.0 for Q4 2023, down 25.22% year-over-year from $141250.0 in Q4 2022, and little changed quarter-over-quarter from $105625.0 in Q3 2023.
Powered by 
Analysis
Palisade Bio (PALI) Receivables - Other (2016 - 2023) Analysis & Trends
Palisade Bio (PALI) has reported Receivables - Other for 7 consecutive years, with $105625.0 the latest figure, recorded in Q4 2023.
- In Q4 2023, Receivables - Other fell 25.22% year-over-year to $105625.0; the TTM figure through Dec 2023 stood at $105625.0 (down 25.22% YoY), while the FY2023 annual figure was $105625.0, down 25.22% from the prior year.
- Receivables - Other held at $105625.0 in Q4 2023 per PALI's latest filing, from $105625.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $229000.0 in Q1 2019 and bottomed at $105625.0 in Q2 2023.
- Historically, Receivables - Other has averaged $187375.0 across 4 years, with a median of $229000.0 in 2019.
- Annual changes were most pronounced in 2019 — Receivables - Other jumped 267.88% — and 2023, when it slipped 25.22%.
- Palisade Bio's Receivables - Other stood at $229000.0 in 2019, then changed by 0.0% to $229000.0 in 2020, then slumped by 38.32% to $141250.0 in 2022, then slipped by 25.22% to $105625.0 in 2023.
- Business Quant data shows PALI's Receivables - Other at $105625.0 in Q4 2023, $105625.0 in Q3 2023, and $105625.0 in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Palisade Bio | 440.73 Mn | 315.53 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 105,625.00 |
| Sep 30, 2023 | 105,625.00 |
| Jun 30, 2023 | 105,625.00 |
| Dec 31, 2022 | 141,250.00 |
| Dec 31, 2020 | 229,000.00 |
| Sep 30, 2020 | 229,000.00 |
| Jun 30, 2020 | 229,000.00 |
| Mar 31, 2020 | 229,000.00 |
| Sep 30, 2019 | 229,000.00 |
| Jun 30, 2019 | 229,000.00 |
| Mar 31, 2019 | 229,000.00 |
| Dec 31, 2018 | 63,938.00 |
| Sep 30, 2018 | 62,248.00 |
| Dec 31, 2017 | 58,784.00 |
| Sep 30, 2017 | 558,000.00 |
| Jun 30, 2017 | 558,000.00 |
| Mar 31, 2017 | 558,000.00 |
| Dec 31, 2016 | 53,081.00 |
| Sep 30, 2016 | 658,000.00 |